Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2021 | The evolution of CTCL treatment

Lauren Pinter-Brown • 27 Aug 2021
SOHO 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Lauren Pinter-Brown, MD, of UCI Health, Chao Family Comprehensive Cancer Center, Orange, CA, talks on the future directions for cutaneous T-cell lymphoma (CTCL) research, hinting at the development of smarter algorithms tailored to individuals for the production of deeper responses. This interview took place during the ninth annual meeting of the Society of Hematologic Oncology (SOHO 2021) congress.

More from Lauren Pinter-Brown

1:16
Treatment of advanced CTCL in 2021
Lauren Pinter-Brown • 27 Aug 2021
1:53
Improving clinical knowledge of CTCL
Lauren Pinter-Brown • 27 Aug 2021
1:15
Risk stratification for CTCL
Lauren Pinter-Brown • 27 Aug 2021
1:24
CTCL management: the challenges faced by clinicians
Lauren Pinter-Brown • 27 Aug 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals